Show simple item record

dc.contributor.authorChua, Su Jen
dc.contributor.authorMol, Ben W.
dc.contributor.authorLongobardi, Salvatore
dc.contributor.authorOrvieto, Raoul
dc.contributor.authorVenetis, Christos A.
dc.contributor.authorLispi, Monica
dc.contributor.authorStorr, Ashleigh
dc.contributor.authorD’Hooghe, Thomas
dc.date.accessioned2021-05-10T14:53:01Z
dc.date.available2021-05-10T14:53:01Z
dc.date.issued2021
dc.identifier.citationChua , S J , Mol , B W , Longobardi , S , Orvieto , R , Venetis , C A , Lispi , M , Storr , A & D’Hooghe , T 2021 , ' Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment : a systematic review and meta-analysis ' , Reproductive Biology and Endocrinology , vol. 19 , no. 1 , 51 . https://doi.org/10.1186/s12958-021-00727-yen
dc.identifier.issn1477-7827
dc.identifier.otherPURE: 193000447
dc.identifier.otherPURE UUID: 0b96d84f-d0f5-4f0e-9b51-4050acacc139
dc.identifier.otherRIS: urn:765EA6FCFD3429F70EFE0D40A95C2EE3
dc.identifier.otherRIS: Chua2021
dc.identifier.otherPubMed: 33794909
dc.identifier.otherPubMedCentral: PMC8017804
dc.identifier.otherScopus: 85103806999
dc.identifier.urihttps://hdl.handle.net/2164/16424
dc.descriptionAcknowledgments Authors would like to thank Dr. Rui Wang (Department of Obstetrics and Gynecology, University of Monash) who contributed to the statistical analysis. Medical writing assistance was provided by Evelina Matekonyte, inScience Communications, Springer Healthcare Ltd., London, UK, and funded by Merck KGaA, Darmstadt, Germany. Funding This study was funded by Merck KGaA, Darmstadt, Germany. Merck KGaA (Darmstadt, Germany) designed and approved the study, took part in data collection and data analysis, and contributed to the data interpretation and final draft of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.en
dc.format.extent13
dc.language.isoeng
dc.relation.ispartofReproductive Biology and Endocrinologyen
dc.rights© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectBiosimilaren
dc.subjectFollitropin alfaen
dc.subjectIVFen
dc.subjectOvarian stimulationen
dc.subjectr-hFSHen
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleBiosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment : a systematic review and meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12958-021-00727-y


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record